Chieh-hung Wu
TPQ, Taiwan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Induced Pluripotent Stem Cell-conditioned Medium Suppressed Melanoma Tumorigenicity Through the Enhancement of Natural-Killer Cellular Immunity.
Journal: Journal of immunotherapy (Hagerstown, Md. : 1997)
Published: March 30, 2016
Brain metastasis features and association with tumor epidermal growth factor receptor mutation in patients with adenocarcinoma of the lung.
Journal: Asia-Pacific journal of clinical oncology
Published: September 05, 2015
Spectrum of cancer risk among Taiwanese with chronic obstructive pulmonary disease.
Journal: International journal of clinical oncology
Published: September 03, 2015
Erlotinib Salvage Therapy in Pulmonary Adenocarcinoma Patients With Disease Progression After Previous EGFR-TKI Treatment.
Journal: American journal of clinical oncology
Published: June 18, 2014
Circulating free mitochondrial DNA concentration and its association with erlotinib treatment in patients with adenocarcinoma of the lung.
Journal: Oncology letters
Published: August 05, 2013
Association between tumor epidermal growth factor receptor mutation and pulmonary tuberculosis in patients with adenocarcinoma of the lungs.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: December 17, 2011
Phase II randomized trial of erlotinib or vinorelbine in chemonaive, advanced, non-small cell lung cancer patients aged 70 years or older.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: December 14, 2011
Plasma epidermal growth factor receptor mutation analysis and possible clinical applications in pulmonary adenocarcinoma patients treated with erlotinib.
Journal: Oncology letters
Published: October 14, 2011
Showing 1-8 of 8
Last Updated: 09/26/2026